Invention Grant
- Patent Title: Cyclopropylamine derivatives useful as LSD1 inhibitors
-
Application No.: US14640395Application Date: 2015-03-06
-
Publication No.: US09676701B2Publication Date: 2017-06-13
- Inventor: Matthew Colin Thor Fyfe , Alberto Ortega Muñoz , Julio Castro-Palomino Laria , Marc Martinell Pedemonte , Maria de los Angeles Estiarte-Martinez , Nuria Valls Vidal
- Applicant: Oryzon Genomics, S.A.
- Applicant Address: ES Cornella de Llobregat, Barcelona
- Assignee: ORYZON GENOMICS, S.A.
- Current Assignee: ORYZON GENOMICS, S.A.
- Current Assignee Address: ES Cornella de Llobregat, Barcelona
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Priority: EP10171345 20100729
- Main IPC: C07C211/40
- IPC: C07C211/40 ; C07C215/64 ; C07C217/64 ; C07C217/74 ; C07C255/53 ; C07C255/54 ; C07C311/08 ; C07C311/09 ; C07C311/21 ; C07D213/38 ; C07D213/40 ; C07D213/42 ; C07D213/56 ; C07D213/57 ; C07D239/26 ; C07D277/28 ; C07D333/20 ; C07D401/04 ; C07D405/04 ; C07D409/04 ; C07C255/59 ; C07D213/64 ; C07D401/10 ; C07D405/10 ; C07D409/10
Abstract:
The invention relates to cyclopropylamine compounds, in particular the compounds of Formula (I), and their use in therapy, including e.g. in the treatment or prevention of cancer, a neurological disease or condition, or viral infection.
Public/Granted literature
- US20160052865A1 CYCLOPROPYLAMINE DERIVATIVES USEFUL AS LSD1 INHIBITORS Public/Granted day:2016-02-25
Information query
